UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma

Gene therapy, 2010-06, Vol.17 (6), p.692-708

2010

Volltextzugriff (PDF)

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege

Cancer cell, 2004-03, Vol.5 (3), p.241-251

2004

Volltextzugriff (PDF)

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

Nature (London), 1990-12, Vol.348 (6303), p.699-704

1990

Volltextzugriff (PDF)

Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor

Gene therapy, 1998-12, Vol.5 (12), p.1584-1592

1998

Volltextzugriff (PDF)

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response

Gene therapy, 1999-10, Vol.6 (10), p.1705-1712

1999

Volltextzugriff (PDF)

The Expression of the Secreted Protein Acidic and Rich in Cysteine (SPARC) Is Associated with the Neoplastic Progression of Human Melanoma

Journal of investigative dermatology, 1997-02, Vol.108 (2), p.210-214

1997

Volltextzugriff (PDF)

Hippocampal SPARC regulates depression‐related behavior

Genes, brain and behavior, 2012-11, Vol.11 (8), p.966-976

2012

Volltextzugriff (PDF)

A novel doxycycline inducible autoregulatory plasmid which displays 'on'/'off' regulation suited to gene therapy applications

Gene therapy, 2000-12, Vol.7 (24), p.2061-2070

2000

Volltextzugriff (PDF)

Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells

Cancer research (Chicago, Ill.), 2000-12, Vol.60 (23), p.6696-6703

2000

Volltextzugriff (PDF)

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

Nature medicine, 1997-02, Vol.3 (2), p.171-176

1997

Volltextzugriff (PDF)

Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor

Gene therapy, 1995-12, Vol.2 (10), p.731

1995

Volltextzugriff (PDF)

Expression of Cathepsin D in Primary and Metastatic Human Melanoma and Dysplastic Nevi

Journal of investigative dermatology, 1995-03, Vol.104 (3), p.340-344

1995

Volltextzugriff (PDF)

Subpopulations of MCf7 Cells Separated by Percoll Gradient Centrifugation: A Model to Analyze the Heterogeneity of Human Breast Cancer

Proceedings of the National Academy of Sciences - PNAS, 1987-10, Vol.84 (20), p.7295-7299

1987

Volltextzugriff (PDF)

Cytokine Gene Therapy in Experimental Allergic Encephalomyelitis by Injection of Plasmid DNA-Cationic Liposome Complex into the Central Nervous System

The Journal of immunology (1950), 1998-05, Vol.160 (10), p.5181-5187

1998

Volltextzugriff (PDF)

Ethical aspects of gene therapy

Medicina (Buenos Aires), 1998, Vol.58 (2), p.229

1998

Volltextzugriff (PDF)

Immuno- and genetic therapy in autoimmune diseases

Genes and immunity, 2000-06, Vol.1 (5), p.295-307

2000

Volltextzugriff (PDF)

Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model

Gene therapy, 1997-06, Vol.4 (6), p.553-559

1997

Volltextzugriff (PDF)

Translational cancer research comes of age in Latin America

Science translational medicine, 2015-12, Vol.7 (319), p.319fs50

2015

Volltextzugriff (PDF)

Gene therapy for rheumatoid arthritis: Theoretical considerations

Drugs & aging, 1998, Vol.12 (1), p.29-41

1998

Volltextzugriff (PDF)

International hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions

Matrix biology, 2004-04, Vol.23 (1), p.63-69

2004

Volltextzugriff (PDF)

Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis model

Gene therapy, 1997-06, Vol.4 (6), p.553-559

1997

Volltextzugriff (PDF)

Bias in Estimations of DNA Content by Competitive Polymerase Chain Reaction

Analytical biochemistry, 2000-12, Vol.287 (1), p.87-94

2000

Volltextzugriff (PDF)

Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias

The International journal of biological markers, 1994-07, Vol.9 (3), p.125-134

1994

Volltextzugriff (PDF)

Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model

Cellular and molecular biology (Noisy-le-Grand, France), 1996-07, Vol.42 (5), p.769

1996

Volltextzugriff (PDF)

In vitro analysis of the cellular proliferative response to 17‐β‐estradiol of human breast cancer

Cancer, 1988-05, Vol.61 (9), p.1807-1812

1988

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(52)
Tagungsberichte
(1)

Sprache

Englisch
(49)
Spanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(40)
Humans
(34)
Animals
(31)
Mice
(23)
Biological And Medical Sciences
(19)
Female
(14)
Biochemistry & Molecular Biology
(13)
Male
(13)
Cell Biology
(12)
Medical Sciences
(12)
Oncology
(11)
Genetic Therapy - Methods
(10)
Medicine, Research & Experimental
(10)
Research & Experimental Medicine
(10)
Tumors
(10)
Gene Therapy
(9)
Genetics & Heredity
(9)
Tumor Cells, Cultured
(9)
Biotechnology & Applied Microbiology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response

The Expression of the Secreted Protein Acidic and Rich in Cysteine (SPARC) Is Associated with the Neoplastic Progression of Human Melanoma

Hippocampal SPARC regulates depression‐related behavior

A novel doxycycline inducible autoregulatory plasmid which displays 'on'/'off' regulation suited to gene therapy applications

Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor

Expression of Cathepsin D in Primary and Metastatic Human Melanoma and Dysplastic Nevi

Subpopulations of MCf7 Cells Separated by Percoll Gradient Centrifugation: A Model to Analyze the Heterogeneity of Human Breast Cancer

Cytokine Gene Therapy in Experimental Allergic Encephalomyelitis by Injection of Plasmid DNA-Cationic Liposome Complex into the Central Nervous System

Ethical aspects of gene therapy

Immuno- and genetic therapy in autoimmune diseases

Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model

Translational cancer research comes of age in Latin America

Gene therapy for rheumatoid arthritis: Theoretical considerations

International hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions

Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis model

Bias in Estimations of DNA Content by Competitive Polymerase Chain Reaction

Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias

Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model

In vitro analysis of the cellular proliferative response to 17‐β‐estradiol of human breast cancer

Suchergebnisse filtern